Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Seaside Therapeutics, Inc."
Count: 14
Selected: 0
| NCT ID | Title |
|---|
| NCT01706523 | Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders | ||
| NCT01555333 | An Open Label Extension Study in Subjects With Fragile X Syndrome | ||
| NCT01325220 | Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome | ||
| NCT01288716 | Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders | ||
| NCT01282268 | Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome | ||
| NCT00892580 | Biomarker and DNA Collection in Subjects Participating in Protocol 22003 | ||
| NCT00823368 | Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001 | ||
| NCT00846547 | Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders | ||
| NCT00788073 | Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome | ||
| NCT01325740 | A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome | ||
| NCT01064973 | An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders | ||
| NCT01013480 | An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome | ||
| NCT00965432 | A Single-Dose Study in Normal Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of STX107 | ||
| NCT01172509 | TMS Measures of Plasticity and Excitatory/Inhibitory Ratio as Biomarkers: R-baclofen Effects in Normal Volunteers |
